STZ vs TARS · P/E 14, rev $9.14B vs rev $336.0M
Constellation Brands Inc Class A (STZ) versus Tarsus Pharmaceuticals Inc (TARS) — a side-by-side from cached financials, not a winner call.
Constellation Brands Inc Class A (STZ) is a beverages - brewers company listed on US.
Tarsus Pharmaceuticals Inc (TARS) is a biotechnology company listed on NASDAQ.
Latest reported STZ revenue for 2026-02-28 was $9.14B. Net income was $1.69B. Revenue was up 322.3% from 2025-02-28 to 2026-02-28. STZ currently screens at market cap $23.73B and trailing P/E 14.4.
Latest reported TARS revenue for 2026-06-30 was $336.0M. Net income was -$25.5M. TARS currently screens at market cap $2.66B.
STZ currently screens at market cap $23.73B and trailing P/E 14.4. TARS currently screens at market cap $2.66B.
Not investment advice. Open the STZ and TARS stock pages for the full models.
Not investment advice.